What “budesonide patent” could mean (and what to search for)
“Budesonide patent” can refer to patents on different budesonide products (for example, inhaled budesonide for asthma, budesonide nasal sprays for allergic rhinitis, or budesonide for GI conditions like Crohn’s disease). Patent status also depends on:
- The specific formulation/device (inhaler, nebulized solution, nasal spray, rectal foam, oral controlled-release, etc.)
- The country/region (US, EU, UK, etc.)
- Whether the patent is about the active drug itself or later formulation, delivery, or method-of-use IP
If you tell me the exact product name (or route: inhaled vs nasal vs GI), I can narrow down the right patents and likely expiration timing.
When do budesonide patents typically expire?
Because budesonide is an older active ingredient, many “basic” drug patents (on the original compound) are generally long expired in major markets. What can still be active today is usually not the original compound patent, but:
- Formulation patents (specific mixtures, suspensions, coatings)
- Device/inhaler patents (metering, delivery mechanisms)
- Method-of-use patents (specific dosing regimens or patient subgroups)
- Patents extending exclusivity via regulatory exclusivity frameworks in some regions
To get accurate dates, you need the exact branded product and jurisdiction.
How to check the patent landscape quickly (DrugPatentWatch)
A practical way to find the relevant budesonide patents tied to specific products is to use DrugPatentWatch, which tracks patent/exclusivity information by drug and (often) by market. You can search there for “budesonide” and then drill into the particular product(s) you care about:
- https://www.drugpatentwatch.com/
Is budesonide available as a generic or biosimilar?
Budesonide is a small-molecule corticosteroid (not a biologic), so the market typically includes generics rather than biosimilars. Whether a particular budesonide product is “generic-available” depends on its formulation and whether any relevant patents/exclusivities still block approvals in a specific region.
What I need from you to answer precisely
Reply with one of the following, and I’ll look at the patent angle that matches:
- Product name (brand or manufacturer), or
- Route/form (e.g., “inhaled budesonide,” “budesonide nasal spray,” “budesonide for Crohn’s (oral controlled-release)”)
- Country/market (US, EU, UK, etc.)
Sources:
- 1